Luigina Graziosi
Perugia, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
The Farnesoid X receptor-bile acid axis contributes to immune evasion in gastric cancer and its inhibition enhances efficacy of anti-PD-L1 therapy.
Journal: Biochemistry and biophysics reports
Published: May 11, 2026
Radiotherapy as an antihemorrhagic approach in gastric cancer: the RANTIGA study.
Journal: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Published: March 10, 2026
Tumor-Derived LIF Promotes GDF15-Driven Cachexia and Adverse Outcomes in Gastric Cancer.
Journal: Cells
Published: December 29, 2025
Pharmacological inhibition of LIF signaling reverses PD-L1-mediated immune suppression in gastric cancer.
Journal: Translational oncology
Published: August 22, 2025
Textbook outcome in gastric cancer surgery: a multicenter cohort study and proposal for a new specific index (TOGS).
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: May 29, 2025
Survival prognostic impact of post-surgical complications in gastric cancer patients after neoadjuvant chemotherapy: a single western center analysis.
Journal: Updates in surgery
Published: February 21, 2025
The Role of Staging Laparoscopy in Stage IV Gastric Cancer Patients.
Journal: Digestive surgery
Published: March 29, 2024
Enhanced recovery after surgery (ERAS) implementation in cytoreductive surgery (CRS) and hyperthermic IntraPEritoneal chemotherapy (HIPEC): Insights from Italian peritoneal surface malignancies expert centers.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: March 07, 2024
Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases.
Journal: ESMO open
Published: December 20, 2023
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis.
Journal: Biochemical pharmacology
Published: December 04, 2023
Oligometastatic Gastric Cancer: Clinical Data from the Meta-Gastro Prospective Register of the Italian Research Group on Gastric Cancer.
Journal: Cancers
Published: November 18, 2023
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: October 14, 2023
Last Updated: 09/26/2026